ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2025

Author's Reply to Peronard and Mayntz: "SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect".

David Aristizábal-Colorado et al.PubMed ↗Publisher ↗

No numbers read from the abstract.